Pyruvate dehydrogenase E1 component subunit alpha (PDHA1) (PDHA1)

The Pyruvate dehydrogenase E1 component subunit alpha (PDHA1) is the primary regulatory subunit of the Pyruvate Dehydrogenase Complex (PDC), which links glycolysis to the citric acid cycle by converting pyruvate into acetyl-CoA (UniProt P08559). This conversion is a multi-step process where PDHA1 catalyzes the rate-limiting oxidative decarboxylation of pyruvate, a reaction that requires the essential cofactor thiamine pyrophosphate (TPP) to bind at a specific catalytic site (PubChem CID 1132). As a critical metabolic checkpoint, PDHA1 activity determines the flux of carbohydrates into mitochondrial respiration versus anaerobic fermentation. Mutations in the PDHA1 gene are the leading cause of Pyruvate Dehydrogenase Deficiency, a condition characterized by life-threatening lactic acidosis and progressive neurological deterioration (StatPearls NBK541073). In oncology, PDHA1 is frequently downregulated or inhibited by pyruvate dehydrogenase kinases to facilitate the Warburg effect, supporting rapid tumor growth through aerobic glycolysis (PubMed PMID: 24561201). Therapeutic strategies targeting this site include the administration of thiamine or its lipophilic analogs, such as benfotiamine, to enhance enzyme activity in patients with partial deficiency or metabolic disorders. Furthermore, small molecules that modulate the phosphorylation state of the E1 alpha subunit are being investigated for their potential to treat diabetes and cardiovascular diseases by restoring glucose oxidation.

Other names

PDHE1-alphaPHE1APyruvate dehydrogenase (lipoamide) alpha 1PDH E1 alphaPyruvate dehydrogenase E1 alpha subunit

Cofactor binding to the E1 alpha subunit to facilitate the oxidative decarboxylation of pyruvate.